Sympathetic control of circulation in hypertension and congestive heart failure

A. Lanfranchi, D. Spaziani, G. Seravalle, C. Turri, R. Dell'Oro, G. Grassi, G. Mancia

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Adrenergic overactivity is a common hallmark of both essential hypertension and congestive heart failure. Indirect and direct measures of sympathetic function have clearly shown that sympathetic activation characterizes essential hypertension. This adrenergic overactivity appears to be related to the severity of the hypertensive state, being detectable in its early stages and showing a progressive increase with the severity of the disease. Essential hypertension is also associated with an impaired baroreflex control of vagal activity, whereas baroreceptor modulation of sympathetic nerve traffic remains unaltered, although undergoing a resetting phenomenon. In contrast, secondary hypertension is not associated with an increased adrenergic activity, thus suggesting that an enhancement in efferent sympathetic outflow is a peculiar feature of essential hypertension. Congestive heart failure is a condition also characterized by sympathetic activation, whose degree is proportional to the clinical severity of the disease. This is paralleled by an impairment in arterial baroreceptor modulation of both vagal and sympathetic activity, thus suggesting that the adrenergic overactivity in congestive heart failure is triggered by a reduced afferent restraint on the vasomotor centre. Chronic angiotensin-converting enzyme inhibition reduces the degree of both sympathetic activation and baroreflex dysfunction occurring in heart failure patients, a finding which documents that the neurohumoral abnormalities can be at least partially reversed by pharmacologic treatment.

Original languageEnglish
Pages (from-to)40-45
Number of pages6
JournalBlood Pressure, Supplement
Volume7
Issue number3
Publication statusPublished - 1998

Fingerprint

Adrenergic Agents
Heart Failure
Hypertension
Pressoreceptors
Baroreflex
Peptidyl-Dipeptidase A
Essential Hypertension
Therapeutics

Keywords

  • Autonomic nervous system
  • Baroreceptors
  • Congestive heart failure
  • Essential hypertension
  • Secondary hypertension
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Cite this

Lanfranchi, A., Spaziani, D., Seravalle, G., Turri, C., Dell'Oro, R., Grassi, G., & Mancia, G. (1998). Sympathetic control of circulation in hypertension and congestive heart failure. Blood Pressure, Supplement, 7(3), 40-45.

Sympathetic control of circulation in hypertension and congestive heart failure. / Lanfranchi, A.; Spaziani, D.; Seravalle, G.; Turri, C.; Dell'Oro, R.; Grassi, G.; Mancia, G.

In: Blood Pressure, Supplement, Vol. 7, No. 3, 1998, p. 40-45.

Research output: Contribution to journalArticle

Lanfranchi, A, Spaziani, D, Seravalle, G, Turri, C, Dell'Oro, R, Grassi, G & Mancia, G 1998, 'Sympathetic control of circulation in hypertension and congestive heart failure', Blood Pressure, Supplement, vol. 7, no. 3, pp. 40-45.
Lanfranchi, A. ; Spaziani, D. ; Seravalle, G. ; Turri, C. ; Dell'Oro, R. ; Grassi, G. ; Mancia, G. / Sympathetic control of circulation in hypertension and congestive heart failure. In: Blood Pressure, Supplement. 1998 ; Vol. 7, No. 3. pp. 40-45.
@article{de9941d70fc84bc2a28aad89bbe39fb4,
title = "Sympathetic control of circulation in hypertension and congestive heart failure",
abstract = "Adrenergic overactivity is a common hallmark of both essential hypertension and congestive heart failure. Indirect and direct measures of sympathetic function have clearly shown that sympathetic activation characterizes essential hypertension. This adrenergic overactivity appears to be related to the severity of the hypertensive state, being detectable in its early stages and showing a progressive increase with the severity of the disease. Essential hypertension is also associated with an impaired baroreflex control of vagal activity, whereas baroreceptor modulation of sympathetic nerve traffic remains unaltered, although undergoing a resetting phenomenon. In contrast, secondary hypertension is not associated with an increased adrenergic activity, thus suggesting that an enhancement in efferent sympathetic outflow is a peculiar feature of essential hypertension. Congestive heart failure is a condition also characterized by sympathetic activation, whose degree is proportional to the clinical severity of the disease. This is paralleled by an impairment in arterial baroreceptor modulation of both vagal and sympathetic activity, thus suggesting that the adrenergic overactivity in congestive heart failure is triggered by a reduced afferent restraint on the vasomotor centre. Chronic angiotensin-converting enzyme inhibition reduces the degree of both sympathetic activation and baroreflex dysfunction occurring in heart failure patients, a finding which documents that the neurohumoral abnormalities can be at least partially reversed by pharmacologic treatment.",
keywords = "Autonomic nervous system, Baroreceptors, Congestive heart failure, Essential hypertension, Secondary hypertension, Sympathetic nervous system",
author = "A. Lanfranchi and D. Spaziani and G. Seravalle and C. Turri and R. Dell'Oro and G. Grassi and G. Mancia",
year = "1998",
language = "English",
volume = "7",
pages = "40--45",
journal = "Blood Pressure, Supplement",
issn = "0803-8023",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - Sympathetic control of circulation in hypertension and congestive heart failure

AU - Lanfranchi, A.

AU - Spaziani, D.

AU - Seravalle, G.

AU - Turri, C.

AU - Dell'Oro, R.

AU - Grassi, G.

AU - Mancia, G.

PY - 1998

Y1 - 1998

N2 - Adrenergic overactivity is a common hallmark of both essential hypertension and congestive heart failure. Indirect and direct measures of sympathetic function have clearly shown that sympathetic activation characterizes essential hypertension. This adrenergic overactivity appears to be related to the severity of the hypertensive state, being detectable in its early stages and showing a progressive increase with the severity of the disease. Essential hypertension is also associated with an impaired baroreflex control of vagal activity, whereas baroreceptor modulation of sympathetic nerve traffic remains unaltered, although undergoing a resetting phenomenon. In contrast, secondary hypertension is not associated with an increased adrenergic activity, thus suggesting that an enhancement in efferent sympathetic outflow is a peculiar feature of essential hypertension. Congestive heart failure is a condition also characterized by sympathetic activation, whose degree is proportional to the clinical severity of the disease. This is paralleled by an impairment in arterial baroreceptor modulation of both vagal and sympathetic activity, thus suggesting that the adrenergic overactivity in congestive heart failure is triggered by a reduced afferent restraint on the vasomotor centre. Chronic angiotensin-converting enzyme inhibition reduces the degree of both sympathetic activation and baroreflex dysfunction occurring in heart failure patients, a finding which documents that the neurohumoral abnormalities can be at least partially reversed by pharmacologic treatment.

AB - Adrenergic overactivity is a common hallmark of both essential hypertension and congestive heart failure. Indirect and direct measures of sympathetic function have clearly shown that sympathetic activation characterizes essential hypertension. This adrenergic overactivity appears to be related to the severity of the hypertensive state, being detectable in its early stages and showing a progressive increase with the severity of the disease. Essential hypertension is also associated with an impaired baroreflex control of vagal activity, whereas baroreceptor modulation of sympathetic nerve traffic remains unaltered, although undergoing a resetting phenomenon. In contrast, secondary hypertension is not associated with an increased adrenergic activity, thus suggesting that an enhancement in efferent sympathetic outflow is a peculiar feature of essential hypertension. Congestive heart failure is a condition also characterized by sympathetic activation, whose degree is proportional to the clinical severity of the disease. This is paralleled by an impairment in arterial baroreceptor modulation of both vagal and sympathetic activity, thus suggesting that the adrenergic overactivity in congestive heart failure is triggered by a reduced afferent restraint on the vasomotor centre. Chronic angiotensin-converting enzyme inhibition reduces the degree of both sympathetic activation and baroreflex dysfunction occurring in heart failure patients, a finding which documents that the neurohumoral abnormalities can be at least partially reversed by pharmacologic treatment.

KW - Autonomic nervous system

KW - Baroreceptors

KW - Congestive heart failure

KW - Essential hypertension

KW - Secondary hypertension

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=0032234937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032234937&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 40

EP - 45

JO - Blood Pressure, Supplement

JF - Blood Pressure, Supplement

SN - 0803-8023

IS - 3

ER -